Publication | Open Access
Phase I dose-escalation study of the thioxanthone SR271425 administered intravenously once every 3 weeks in patients with advanced malignancies
10
Citations
9
References
2008
Year
OncologyThioxanthone Sr271425Metronomic TherapyPharmacologyPharmacotherapyMetronomic ChemotherapyAdvanced MalignanciesCancer TreatmentMedicineCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1